Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000803891 | SCV000943778 | likely benign | Fanconi anemia | 2024-06-26 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001276569 | SCV001481408 | uncertain significance | Fanconi anemia complementation group A | 2020-09-18 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV004972973 | SCV005586495 | likely benign | Inborn genetic diseases | 2024-11-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001276569 | SCV005639584 | uncertain significance | Fanconi anemia complementation group A | 2024-05-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001276569 | SCV001462967 | uncertain significance | Fanconi anemia complementation group A | 2020-01-17 | no assertion criteria provided | clinical testing |